Special Issue "Advances in Amorphous Drug Formulations, Volume II"
Deadline for manuscript submissions: 31 October 2023 | Viewed by 10550
Interests: amorphous drugs and formulations; co-amorphous drug delivery; silica based drug delivery systems; functional excipients
Special Issues, Collections and Topics in MDPI journals
Special Issue in Pharmaceutics: Advances in Amorphous Drug Formulations
Amorphous drug delivery systems are one of the most promising technologies to tackle the issue of poor bioavailability of an increasing number of poorly soluble drugs in the development pipelines. Due to the poor physical stability of pure amorphous drugs, formulation scientists frequently use different types of excipients to stabilize the drug in its amorphous form, including different types of polymeric carriers, mesoporous materials or other low molecular weight excipients. The mechanism of stabilization has been attributed to the properties of the chosen excipient and the drug, such as drug-excipient miscibility, antiplasticization, molecular interactions, etc. However, whilst more and more products have reached the market in the past few years, the amorphous form and amorphous formulations still remain not fully understood. This Special Issue serves to capture the contemporary progress in the field of amorphous formulations, both from a fundamental understanding and their practical application.
Prof. Dr. Korbinian Löbmann
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- poorly soluble drugs
- high energy solids
- amorphous form
- glass solutions
- solid state miscibility
- amorphous solid dispersions (ASDs)
- polymeric carriers
- mesoporous silica